Wayne Hsing-Yuan Ting sold $2.5M of LIME
Chief Executive Officer at Neutron Holdings, Inc.. 99,115 shares at an average of $25.00, traded Jul 2, 2026, filed Jul 2, 2026.
Score components
- +25RoleCEO
- +25Trade size$2.5M at market
- +5Share of holdings soldSold 19% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001140361-26-027486, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | DDisposition to issuer Common Stock | -23,266 | - | - | 559,667 | Jul 2, 2026 |
| Jun 30, 2026 | FTax withholding Common Stock | -27,201 | $25.00 | $680k | 532,466 | Jul 2, 2026 |
| Jul 2, 2026 | SOpen-market sale Common Stock | -99,115 | $25.00 | $2.5M | 433,351 | Jul 2, 2026 |
Related signals
Other insiders at Neutron Holdings, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 48Moderate | Neutron Holdings, Inc. | Zhoujia Bao director | $1.8M 73,397 shares | -10% | |
| 35Weak | LIMEbuy Neutron Holdings, Inc. | Uber Technologies, Inc owner | $20M 800,000 shares | +6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.